歡迎光臨源葉生物,登錄 | 注冊 |
當前位置: 首頁 > 小分子抑制劑 > Apoptosis > AZD8055

瀏覽歷史

S80013

AZD8055

源葉(MedMol) 98%
  • 英文名:
  • (5-(2,4-bis((S)-3-methylmorpholino)pyrido[2,3-d]pyrimidin-7-yl)-2-methoxyphenyl)methanol
  • 別名:
  • 5-[2,4-雙[(3S)-3-甲基-4-嗎啉]吡啶并[2,3-d]嘧啶-7-基]-2-甲氧基苯甲醇;[5-[2,4-bis[(3S)-3-methylmorpholin-4-yl]pyrido[2,3-d]pyrimidin-7-yl]-2-methoxyphenyl]methanol
  • CAS號:
  • 1009298-09-2
  • 分子式:
  • C25H31N5O4
  • 分子量:
  • 465.56
  • 核磁/質譜:
品牌貨號產品規(guī)格價格(RMB) 庫存(上海) 北京 武漢 南京 數量計量單位 加入購物車...
源葉(MedMol) S80013-5mg 98% ¥183.60元 >10 0 0 0 EA 加入購物車
源葉(MedMol) S80013-10mg 98% ¥204.00元 >10 0 0 0 EA 加入購物車
源葉(MedMol) S80013-25mg 98% ¥476.00元 >10 0 0 0 EA 加入購物車
源葉(MedMol) S80013-50mg 98% ¥612.00元 >10 0 0 0 EA 加入購物車
源葉(MedMol) S80013-100mg 98% ¥1070.00元 >10 0 0 0 EA 加入購物車
源葉(MedMol) S80013-200mg 98% ¥1632.00元 8 0 0 0 EA 加入購物車
大包裝詢價

提交您的電話號碼并同意《個人信息授權與保護申明》,到貨后將短信提示。
提交

產品介紹

參考文獻

質檢證書(COA)

摩爾濃度計算器

相關產品

  • 提示:詳情請下載說明書。
  • 產品描述: AZD-8055 is a potent, selective, and orally bioavailable ATP-competitive mTOR kinase inhibitor with an IC50 of 0.8 nM. AZD-8055 inhibits both mTORC1 and mTORC2
  • 靶點: mTOR:0.8 nM (IC50);mTORC1;mTORC2;Autophagy;Apoptosis;mTOR;Autophagy
  • 體內研究:
    In mice bearing U87-MG (PTEN null) glioblastoma xenografts, oral treatment with AZD-8055 (AZD8055) results in a dose-dependent tumor growth inhibition of 33%, 48%, and 77% with 2.5, 5, and 10 mg/kg/d twice daily, respectively. A similar dose dependency is observed in nude mice bearing A549 xenografts: tumor growth inhibition is 44%, 55%, and 93% after 2.5, 5, and 10 mg/kg/d twice daily, respectively. AZD8055 also results in significant inhibition of tumor growth and/or regression in breast, lung, colon, prostate, and uterine xenograft models when administered either twice daily at 10 mg/kg or daily at a dose of 20 mg/kg. AZD8055 markedly decreases the phosphorylation levels of mTOR and its substrates and the activation of microglia in vivo, and promotes the microglial polarization from M1 phenotype to M2 phenotype. In addition, administration of AZD8055 following subarachnoid hemorrhage (SAH) significantly ameliorates EBI, including neuronal apoptosis, neuronal necrosis, brain edema and blood-brain barrier permeability
  • 參考文獻:
    1. Chresta CM, et al. AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mammalian target of rapamycin kinase inhibitor with in vitro and in vivo antitumor activity. Cancer Res, 2010, 70(1), 288-298.2. You W, et al. Inhibition of mammalian target of rapamycin attenuates early brain injury through modulating microglial polarization after experimental subarachnoid hemorrhage in rats. J Neurol Sci. 2016 Aug 15;367:224-31. 3. Kawata T, et al. Dual inhibition of the mTORC1 and mTORC2 signaling pathways is a promising therapeutic target for adult T-cell leukemia. Cancer Sci. 2017 Oct 27.
  • 溶解性: DMSO  :  33.33  mg/mL  (71.59  mM;  Need  ultrasonic)
  • 保存條件: -20℃
  • 配置溶液濃度參考:
    1mg 5mg 10mg
    1 mM 2.148 ml 10.74 ml 21.48 ml
    5 mM 0.43 ml 2.148 ml 4.296 ml
    10 mM 0.215 ml 1.074 ml 2.148 ml
    50 mM 0.043 ml 0.215 ml 0.43 ml
  • 注意:部分產品我司僅能提供部分信息,我司不保證所提供信息的權威性,僅供客戶參考交流研究之用。
輸入產品批號:

本計算器可幫助您計算出特定溶液中溶質的質量、溶液濃度和體積之間的關系,公式為:


質量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)


  • =
    *
    *


源葉所有產品僅用作科學研究,銷售產品行為均適用于我司網上所列通用銷售條款。